| Date | Analyst Firm | Rating | Price Estimate | Condition |
|---|---|---|---|---|
| 11/26/12 | Citigroup | Buy | $675 | Coverage Initiated |
| 11/19/12 | Merrill Lynch | Buy | $780 | Price Decreased |
| 10/26/12 | Pacific Crest | Outperform | $670 | Price Decreased |
| 10/26/12 | Morgan Stanley | Overweight | $714 | Price Decreased |
| 10/26/12 | Goldman Sachs | Buy | $760 | Price Decreased |
| 10/26/12 | Piper Jaffray | Buy | $900 | Price Decreased |
| 10/18/12 | Janney Montgomery Scott | Buy | $745 | Price Increased |
| 10/18/12 | BMO | Outperform | $730 | Price Decreased |
| 09/21/12 | Deutsche Bank | Buy | $850 | Price Increased |
| 09/17/12 | Bank of America/Merrill Lynch | Buy | $850 | Price Increased |
| 09/13/12 | RW Baird | Buy | $750 | Price Increased |
| 09/13/12 | FBN Securities | Buy | $1000 | Price Increased |
| 09/13/12 | Bernstein Research | Buy | $800 | Price Increased |
| 09/4/12 | Wedbush Securities | Buy | $885 | Price Increased |
| 08/22/12 | Needham & Co. | Buy | $750 | Price Increased |
| 08/17/12 | Jefferies | Conviction List Buy | $900 | Price Increased |
| 08/9/12 | Stifel Nicolaus | Buy | $825 | Coverage Initiated |
| 06/12/12 | Canaccord Genuity | Buy | $800 | Price Increased |
| 05/24/12 | Oppenheimer | Outperform | $680 | Price Decreased |
| 05/15/12 | Stern Agee | Buy | $780 | Price Increased |
| 05/15/12 | Barclays Capital | Buy | $750 | Price Reiterated |
| 05/14/12 | Topeka Capital | Buy | $1,111 | Price Reiterated |
| 05/11/12 | Credit Suisse | Outperform | $750 | Price Increased |
| 04/26/12 | Topeka Capital | Buy | $1,111 | Price Increased |
| 04/25/12 | Auriga | Buy | $700 | Price Reiterated |
| 04/09/12 | BTIG | Neutral | $600 | Downgrade |
Price estimates generally refer to the expected stock price one year from the estimate date.
